David I. Chemerow

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Ocala, FL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ David I Chemerow
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David I. Chemerow

Form 4 holding Director

RiceBran Technologies

Security class
Deferred Stock Units
Shares / value
198,545
Estimated value
$142,913
Report date
31 Dec 2023
Price
$0.7198
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

RiceBran Technologies

Security class
Common Stock
Shares / value
194,217
Estimated value
$139,797
Report date
03 Jan 2024
Price
$0.7198
Ownership
Direct
Form 4 holding Director

RiceBran Technologies

Security class
Common Stock
Shares / value
26,033
Estimated value
$18,739
Report date
03 Jan 2024
Price
$0.7198
Ownership
The David I. Chemerow 1992 Trust
Form 4 holding Director

AIM ImmunoTech Inc.

Security class
Class G Warrants
Shares / value
50,000
Estimated value
Report date
06 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

AIM ImmunoTech Inc.

Security class
Series G Convertible Preferred Stock
Shares / value
25
Estimated value
Report date
06 Mar 2026
Price
Ownership
Direct
Underlying class
Series G Convertible Preferred Stock
Underlying amount
Form 4 holding Director

AIM ImmunoTech Inc.

Security class
Series G Convertible Prefered Stock
Shares / value
0
Estimated value
Report date
12 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by David I. Chemerow

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .